Replies to post #353710 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I know they have said it because I have explained that very point myself when people were inpatient in the past. Where or when, is not my problem. I am telling you it has been said, and I believe repeatedly, in public statements. I think you can probably find it easily, but no, I am about to get on important calls, I am not going to hunt that down for you.

[biosectinvestor]

I don’t agree. I think they clearly indicated it and it is LOGICALLY consistent that that is what they meant, as well. I’ve made the point in the past, I am confident in my interpretation.

[sentiment_stocks]

But that's not the same as delaying TLD until a journal article is published, which is what the backchannels have suggested is what the company is doing, at the advice of their "advisors."

I'm sorry, I don't believe that I indicated that I thought their advisors were suggesting that the company delay the release of top line data until a journal article is published. I don't know what their advisors are advising them, but I believe that their last PR indicated they were planning to publicly announce it and prepare it for scientific publication.

I'd imagine that if the company plans to publish the data in a scientific publication (which is what they indicated), and the journal would allow them to publicly announce it (which is what they said) beforehand, then unless something changes, that's what they'll do.

They are all still alive. Writing a shareholder letter to tell you that is probably something their legal counsel would advise them not to do.

I think the hardest thing about holding this stock and not selling for a modest gain is that if this turns out poorly, I will have known better. It is the platform potential of this stock that is keeping me here...the understanding that if DCVAX-L works, it will work for other indications, and that should give us a value of at least $8.0 billion, as that should be a floor for any potential acquisition.

It seems that you understand the risk reward thing here.

But there are so many red flags that I know and understand are HUGE red flags...I'm going to be very mad at myself if I ignored the obvious warning signs and this turns out to be a bust, or the patient population is too low to justify what is already a very high pre-data release market cap, etc.

When you've been here as long as some of us, you've seen the red flags pop up, time and time again, only to see them put back down when the explanation as to what was behind it comes out. You haven't been on this board for too long, and if you're a fairly recent shareholder of the stock, there are are perhaps too many rabbit holes to dive down into before you'd get to the bottom and, IMO, be okay with the answer. What I can say, I think, is that there are many long time longs on this board, that have been buying as the share price fell, and that don't have trailing stops on their shares, and plan to hold a good many of their shares for a fairly long time into the future. Some of those people have publicly (on this board) bemoaned things they didn't know, until they knew the back story, or the theory(ies) for the back story (i.e. the halt) which inevitably comes out in time.

Long NWBO shareholders have learned over many years to be patient. And many of them have decided to trust management. And when we see red flags, we are careful to look to see who is coloring them as such.